Skip to main content

Table 4 Changes in blood BNP, LVEDD, and LVEF in the high BNP group

From: Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels

Parameters

Dobutamine (n = 30)

rhBNP (n = 28)

 

Baseline

5 Days

Changes

Baseline

5 Days

Changes

BNP (pg/mL)

1890 ± 742

1261 ± 560**

629 ± 715

1819 ± 665

843 ± 450**ΔΔ

976 ± 566Δ

LVEDD (mm)

63.8 ± 4.6

61.2 ± 6.5**

2.6 ± 4.3

64.3 ± 4.9

60.9 ± 5.7**

3.3 ± 3.2

LVEF (%)

32.1 ± 6.1

39.6 ± 10.9**

7.5 ± 8.1

31.3 ± 6.8

43.7 ± 11.2**

12.4 ± 7.5Δ

  1. Abbreviations: LVEDD left ventricle end diastolic dimension, LVEF left ventricular ejection fraction, Other abbreviations are same as in Table 2. Values are mean ± SD. **P < 0.01 (paired t- test) versus baseline; ΔP < 0.05, ΔΔP < 0.01 (unpaired t- test) versus dobutamine.